ASN
SNOA icon

Advisory Services Network’s Sonoma Pharmaceuticals SNOA Stock Holding History

Advisory Services Network’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-123
Closed -$444 – 3349
2023
Q4 		$444 Buy
+123
New +$784 ﹤0.01% 3637
2023
Q2 		– Sell
-123
Closed -$2.4K – 3347
2023
Q1 		$2.4K Buy
+123
New +$3.17K ﹤0.01% 3381

Other funds holding SNOA

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Advisory Services Network's SNOA Position: Q1 2024 in Review

Advisory Services Network sold out of Sonoma Pharmaceuticals (SNOA) in Q1 2024, closing a stake of 123 shares — an estimated $444 sold.

Advisory Services Network first reported a position in SNOA in Q1 2023 and held it in 2 quarters. The position peaked at $2.4K in Q1 2023. 14 funds tracked by Wall St. Rank hold SNOA as of Q1 2024.

  • Advisory Services Network reported no remaining Sonoma Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 123 Sonoma Pharmaceuticals shares in Q1 2024, an estimated $444.
  • Advisory Services Network first reported a position in Sonoma Pharmaceuticals in Q1 2023 and held it in 2 quarters.
  • Advisory Services Network's Sonoma Pharmaceuticals position peaked at $2.4K in Q1 2023.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.